Theremia

Exhibitor

Theremia helps biotech and pharmaceutical companies reduce clinical failure risk by identifying the right patients, endpoints, and trial design, before costly late-stage failures, specializing in Neurology and Psychiatry.  By combining one of the world's largest longitudinal CNS patient datasets, over 1 million records across 9,000 drugs from Europe and the United States, with complex AI models, Theremia delivers regulatory-grade, clinically actionable insights across the full drug lifecycle.

website